Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.79 USD | -1.10% |
|
-4.74% | -9.53% |
05-14 | Cantor Fitzgerald Adjusts Price Target on Exagen to $7 From $5, Maintains Overweight Rating | MT |
05-13 | Exagen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.53% | 31.45M | |
+17.06% | 82.53B | |
-26.96% | 73B | |
-1.13% | 26.4B | |
-10.96% | 17.12B | |
+0.71% | 17.09B | |
-0.36% | 15.23B | |
+73.73% | 13.24B | |
+77.67% | 13.02B | |
-25.09% | 12.82B |
- Stock Market
- Equities
- XGN Stock
- News Exagen Inc.
- Transcript : Exagen Inc., Q3 2021 Earnings Call, Nov 10, 2021